Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells.
暂无分享,去创建一个
[1] Tammy M. Havener,et al. Synergistic drug combinations and machine learning for drug repurposing in chordoma , 2020, Scientific Reports.
[2] Adria Hasan,et al. Hsp90 inhibitor gedunin causes apoptosis in A549 lung cancer cells by disrupting Hsp90:Beclin-1:Bcl-2 interaction and downregulating autophagy. , 2020, Life sciences.
[3] A. Bhattacharjee,et al. Gedunin isolated from the mangrove plant Xylocarpus granatum exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis , 2020, Apoptosis.
[4] H. Zali,et al. HSP90 and Co-chaperones: Impact on Tumor Progression and Prospects for Molecular-Targeted Cancer Therapy , 2020, Cancer investigation.
[5] Tao Tao,et al. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges , 2020, Cell & Bioscience.
[6] Sora Yoon,et al. Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1 , 2020, Experimental & Molecular Medicine.
[7] Yan Fu,et al. Metformin Inhibits Tumor Metastasis through Suppressing Hsp90α Secretion in an AMPKα1-PKCγ Dependent Manner , 2020, Cells.
[8] F. Polticelli,et al. Cytochrome c: An extreme multifunctional protein with a key role in cell fate. , 2019, International journal of biological macromolecules.
[9] M. P. Dobay,et al. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7 , 2019, Science Advances.
[10] K. Tsui,et al. BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells , 2019, Oxidative medicine and cellular longevity.
[11] Rensheng Wang,et al. Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer , 2019, Experimental and therapeutic medicine.
[12] Jai-Sing Yang,et al. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling , 2019, International journal of oncology.
[13] D. Xiao,et al. Novel application of metformin combined with targeted drugs on anticancer treatment , 2018, Cancer science.
[14] Sang-Youel Park,et al. Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS , 2018, International journal of molecular medicine.
[15] Pierre M. Durand,et al. The Nature of Programmed Cell Death , 2018, Biological Theory.
[16] S. Dhamija,et al. Beclin 1 Phosphorylation – at the Center of Autophagy Regulation , 2018, Front. Cell Dev. Biol..
[17] C. Pathak,et al. “Programmed Cell Death: A Process of Death for Survival” – How Far Terminology Pertinent for Cell Death in Unicellular Organisms , 2018, Journal of cell death.
[18] Xingya Wang,et al. Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners , 2018, International journal of molecular sciences.
[19] Shuanying Yang,et al. Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review). , 2017, International journal of oncology.
[20] Sheng-Cai Lin,et al. AMPK: Sensing Glucose as well as Cellular Energy Status. , 2017, Cell metabolism.
[21] Sang-We Kim,et al. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. , 2017, Cancer letters.
[22] X. Xiong,et al. The Interrelation between Reactive Oxygen Species and Autophagy in Neurological Disorders , 2017, Oxidative medicine and cellular longevity.
[23] Y. Jiao,et al. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway , 2017, International journal of biological sciences.
[24] M. Gariboldi,et al. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production , 2017, Scientific Reports.
[25] M. Lohani,et al. Molecular docking analysis of aplysin analogs targeting survivin protein , 2017, Bioinformation.
[26] Ke Chen,et al. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1‐dependent pathway , 2017, Molecular oncology.
[27] K. Tennekoon,et al. In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells , 2017, BioMed research international.
[28] P. Wee,et al. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways , 2017, Cancers.
[29] G. Fimia,et al. Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate , 2017, Front. Oncol..
[30] Herman Yeger,et al. Combination therapy in combating cancer , 2017, Oncotarget.
[31] Mei Peng,et al. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms. , 2017, Cancer treatment reviews.
[32] Ping Li,et al. Caspase-9: structure, mechanisms and clinical application , 2017, Oncotarget.
[33] Z. Wang,et al. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. , 2017, Cancer letters.
[34] R. Subramani,et al. Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway , 2016, Oncotarget.
[35] Adria Hasan,et al. ER chaperone GRP78 regulates autophagy by modulation of p53 localization. , 2017, Frontiers in bioscience.
[36] V. Boudy,et al. Metformin: An anti-diabetic drug to fight cancer. , 2016, Pharmacological research.
[37] J. Petrik,et al. Akt isoform specific effects in ovarian cancer progression , 2016, Oncotarget.
[38] Wei Zheng,et al. Drug combination therapy increases successful drug repositioning. , 2016, Drug discovery today.
[39] A. Brunet,et al. AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs. , 2016, Trends in cell biology.
[40] Na Ye,et al. Direct Activation of Bax Protein for Cancer Therapy , 2016, Medicinal research reviews.
[41] Xiaoming Jiang,et al. Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer , 2016, Autophagy.
[42] E. Gabrielson,et al. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer , 2015, Oncotarget.
[43] Adrianna Skoneczna,et al. Mitochondria-nucleus network for genome stability. , 2015, Free radical biology & medicine.
[44] G. Alexiou,et al. The role of heat shock proteins in cancer. , 2015, Cancer letters.
[45] Nidhi Khurana,et al. Hsp90, the Concertmaster: Tuning Transcription , 2015, Front. Oncol..
[46] T. Mak,et al. Caspase functions in cell death and disease. , 2015, Cold Spring Harbor perspectives in biology.
[47] Osamu Nakamura,et al. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells , 2014, International journal of oncology.
[48] A. Dillin,et al. The role of protein clearance mechanisms in organismal ageing and age-related diseases , 2014, Nature Communications.
[49] Haijian Wu,et al. Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases , 2014, Molecular Neurobiology.
[50] X. Song,et al. Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer , 2014, Cell Death and Disease.
[51] G. Dewson,et al. Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function , 2014, Cell Death and Differentiation.
[52] Jiri Polivka,et al. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. , 2014, Pharmacology & therapeutics.
[53] P. Panda,et al. Autophagy and apoptosis: where do they meet? , 2014, Apoptosis.
[54] Eric H. Baehrecke,et al. Self-consumption: the interplay of autophagy and apoptosis , 2014, Nature Reviews Molecular Cell Biology.
[55] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[56] Anni I. Nieminen,et al. Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis , 2013, Proceedings of the National Academy of Sciences.
[57] G. Takaesu,et al. Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy , 2012, Nature Structural &Molecular Biology.
[58] Peng Huang,et al. Targeting cancer cell mitochondria as a therapeutic approach. , 2013, Future medicinal chemistry.
[59] C. Kieda,et al. ROS implication in a new antitumor strategy based on non‐thermal plasma , 2012, International journal of cancer.
[60] Jing Geng,et al. Hsp90 interacts with AMPK and mediates acetyl-CoA carboxylase phosphorylation. , 2012, Cellular signalling.
[61] H. Rikiishi. Novel Insights into the Interplay between Apoptosis and Autophagy , 2012, International journal of cell biology.
[62] A. Toker. Achieving specificity in Akt signaling in cancer. , 2012, Advances in biological regulation.
[63] K. Pantel,et al. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. , 2011, Cellular signalling.
[64] H. Koo,et al. Roles of AKT1 and AKT2 in non‐small cell lung cancer cell survival, growth, and migration , 2011, Cancer science.
[65] R. Xiang,et al. Functional interaction of heat shock protein 90 and Beclin 1 modulates Toll‐like receptor‐mediated autophagy , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] D. Dickson,et al. Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease , 2011, The Journal of cell biology.
[67] A. Cuervo,et al. Chaperone-mediated autophagy in protein quality control. , 2011, Current opinion in cell biology.
[68] A. Nakagawara,et al. Role of p53 in Cell Death and Human Cancers , 2011, Cancers.
[69] T. Merriam,et al. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia. , 2011, Biochemical and biophysical research communications.
[70] M. Maiuri,et al. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1 , 2010, Oncogene.
[71] C. Kenyon. The genetics of ageing , 2010, Nature.
[72] Mengwei Zang,et al. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. , 2010, Future oncology.
[73] J. Bartlett,et al. Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH , 2010, Histopathology.
[74] D. Rubinsztein,et al. Apoptosis blocks Beclin 1-dependent autophagosome synthesis – an effect rescued by Bcl-xL , 2009, Cell Death and Differentiation.
[75] Sandeep Krishna,et al. Stress-specific response of the p53-Mdm2 feedback loop , 2010, BMC Systems Biology.
[76] Anna Lisa Maniero,et al. Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species. , 2009, Biochimica et biophysica acta.
[77] D. Green,et al. Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.
[78] J. Kim,et al. Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. , 2009, Cancer letters.
[79] N. Hay,et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.
[80] Xin Cai,et al. Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage , 2008, Proceedings of the National Academy of Sciences.
[81] W. Zong,et al. p53 in autophagy control , 2008, Cell cycle.
[82] M. Karin,et al. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2008, Cell.
[83] E. Barrón,et al. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells , 2008, Cell Death and Differentiation.
[84] Nektarios Tavernarakis,et al. Regulation of autophagy by cytoplasmic p53 , 2008, Nature Cell Biology.
[85] W. Bursch,et al. Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes , 2007, Cell Death and Differentiation.
[86] U. Stochaj,et al. Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK-->ERK1/2 pathway. , 2007, American journal of physiology. Cell physiology.
[87] T. Pozzan,et al. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. , 2007, Trends in cell biology.
[88] D. Green,et al. GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase Activation , 2007, Cell.
[89] L. Moretti,et al. Switch Between Apoptosis and Autophagy: Radiation-Induced Endoplasmic Reticulum Stress? , 2007, Cell cycle.
[90] J. Dice. Chaperone-Mediated Autophagy , 2007, Autophagy.
[91] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[92] Thomas Schaffner,et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis , 2006, Nature Cell Biology.
[93] Jinsong Liu,et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.
[94] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[95] T. Fan,et al. Caspase family proteases and apoptosis. , 2005, Acta biochimica et biophysica Sinica.
[96] S. Lindquist,et al. HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.
[97] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[98] Stuart K. Calderwood,et al. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.
[99] Daniel J. Klionsky,et al. Autophagy in Health and Disease: A Double-Edged Sword , 2004, Science.
[100] N. Ruderman,et al. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. , 2004, Biochemical and biophysical research communications.
[101] T. Nishizaki,et al. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. , 2004, Biochemical pharmacology.
[102] Peter Csermely,et al. Response to Associate Editor , 2016 .
[103] L. Rasmussen,et al. Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. , 2003, Nucleic acids research.
[104] Gen Sheng Wu,et al. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line , 2002, Oncogene.
[105] S. Emr,et al. Autophagy as a regulated pathway of cellular degradation. , 2000, Science.
[106] Honglin Zhou,et al. Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level , 2000, The Journal of cell biology.
[107] U Alon,et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[108] Steven J. Sollott,et al. Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.
[109] T. Tsuruo,et al. Modulation of Akt kinase activity by binding to Hsp90. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[110] M. Owen,et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.
[111] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[112] D. Peters,et al. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. , 1995, Drugs.
[113] L. Ji,et al. Effects of Adriamycin on heart mitochondrial function in rested and exercised rats. , 1994, Biochemical pharmacology.